Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-526,555 (varenicline) for smoking cessation
NCT00139750Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in nicotine dependence, sponsored by Pfizer. Started Dec 2004; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00139750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139750.